ABBOTT LABORATORIES — Form 10-Q
Filed November 4, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Robert B. Ford (CEO) and Philip P. Boudreau (CFO) certified on November 4, 2026 that the Q3 2026 10-Q for Abbott Laboratories complies with SEC requirements, financial statements fairly present the company's financial condition and results of operations, and disclosure controls and internal controls over financial reporting are effective. No material weaknesses, significant deficiencies, or fraud involving management were disclosed.
Why this rating
Routine Sarbanes-Oxley certification exhibit; boilerplate attestation required for all public company quarterly filings. No substantive business event, transaction, or control change disclosed.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.